NCT04820127 Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources Use Status COMPLETED Phase NA
NCT04769024 Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia Status COMPLETED Phase NA
NCT04761497 Effects of Group Music Therapy Interventions on Alzheimer's Disease Patients: a Three-arm Randomized Controlled Blind Study. Status COMPLETED Phase NA
NCT04730635 Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) Status COMPLETED Phase PHASE1
NCT04666077 Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Status COMPLETED Phase NA
NCT04603482 Self-Management Intervention: Considering Needs & Preferences of Dementia Caregivers (Caregiver Career Study) Status COMPLETED Phase NA
NCT04476303 A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04445831 A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT04426539 New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study Status COMPLETED Phase N/A
NCT04396873 PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease Status RECRUITING Phase PHASE1
NCT04368572 Efficacy of Hypnosis on Pain and Anxiety During Lumbar Puncture for Etiological Diagnosis of Cognitive Impairment Status UNKNOWN Phase NA
NCT04308304 MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005) Status COMPLETED Phase PHASE1
NCT04305210 Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination Status UNKNOWN Phase PHASE2
NCT04271163 Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT04241068 A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 Status TERMINATED Phase PHASE3
NCT04187547 A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension Status WITHDRAWN Phase PHASE3
NCT04174287 Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease Status UNKNOWN Phase PHASE2